Stevens Capital Management’s CELATOR PHARMACEUTICALS INC. COMMON STOCK CPXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-323,766
Closed -$9.77M 1291
2016
Q2
$9.77M Buy
+323,766
New +$6.57M 0.39% 69

Stevens Capital Management's CPXX Position: Q3 2016 in Review

Stevens Capital Management sold out of CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) in Q3 2016, closing a stake of 323,766 shares — an estimated $9.77M sold.

Stevens Capital Management first reported a position in CPXX in Q2 2016 and held it in 1 quarter. The position peaked at $9.77M in Q2 2016. 0 funds tracked by Wall St. Rank hold CPXX as of Q3 2016.

  • Stevens Capital Management reported no remaining CELATOR PHARMACEUTICALS INC. COMMON STOCK position as of Q3 2016 after selling out during the quarter.
  • Stevens Capital Management sold 323,766 CELATOR PHARMACEUTICALS INC. COMMON STOCK shares in Q3 2016, an estimated $9.77M.
  • Stevens Capital Management first reported a position in CELATOR PHARMACEUTICALS INC. COMMON STOCK in Q2 2016 and held it in 1 quarter.
  • Stevens Capital Management's CELATOR PHARMACEUTICALS INC. COMMON STOCK position peaked at $9.77M in Q2 2016.
  • 0 funds tracked by Wall St. Rank held CELATOR PHARMACEUTICALS INC. COMMON STOCK as of Q3 2016.

Based on Stevens Capital Management's 13F filing for Q3 2016, filed 8 Nov 2016.